Nasal COVID vaccine boost increases IgA responses linked to variant neutralisation

Coronavirus

By Hugo Francisco de Souza Reviewed by Susha Cheriyedath, M.Sc. Feb 15 2026 A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID vaccine strategies.  Study: Intranasal booster drives class switching and homing of memory B cells for mucosal IgA response . Image Credit: Jo Panuwat D / Shutterstock Current intramuscular vaccines excel at eliciting blood-based immunity but

Tag-uri: Coronavirus

din zilele anterioare